| HOME >> MEDICINE >> TECHNOLOGY |
CPT is a registered trademark of the American Medical Association.For Further Information:Uroplasty, Inc.
EVC GroupDavid Kaysen, President and CEO, or
Doug Sherk/Jenifer Kirtland (Investors)Medi Jiwani, Vice President, CFO, and Treasurer
415.568.4887952.426.6140
Chris Gale (Media)646.201.5431UROPLASTY, INC. AND SUBSIDIARIESCONDENSED Consolidated Statements of Operations(Unaudited)Three Months EndedJune 30,20112010Net sales
$4,653,123$3,035,499Cost of goods sold
709,566510,696Gross profit
3,943,5572,524,803Operating expensesGeneral and administrative
1,021,858850,509Research and development
455,760400,629Selling and marketing
3,594,1421,988,526Amortization
212,315210,7685,284,0753,450,432Operating loss
(1,340,518)(925,629)Other income (expense)Interest income
17,83413,628Interest expense
-(1,947)Foreign currency exchange gain (loss)
5,3081,79023,14213,471Loss before income taxes
(1,317,376)(912,158)Income tax expense
13,93117,150Net loss
($1,331,307)($929,308)Basic and diluted loss per common share
($0.06)($0.06)Weighted average common shares outstanding:Basic and diluted
20,629,00015,307,000UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)June 30, 2011March 31, 2011AssetsCurrent assets:Cash and cash equivalents & short-term investments
$14,050,660$14,084,150Accounts receivable, net
2,032,2682,085,262Inventories
714,089677,960Other<
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2010 PR Newswire. All rights reserved |